Skip to main content
. 2013 Nov 12;12:146. doi: 10.1186/1475-2891-12-146

Table 3.

Lipid coronary heart disease risk factor changes during the 12-week study

  Intervention Week 1 1 Week 12 P-value 2 P-value 3 Change 4 P-value 5
Total cholesterol (mg/dl)
 ADF
 201 ± 9
 175 ± 12
 <0.01
 0.12
 -26 ± 6
 0.50
 
 Control
 211 ± 11
 202 ± 9
 0.54
  
 -9 ± 5
  
LDL cholesterol (mg/dl)
 ADF
 118 ± 9
 99 ± 9
 0.01
 0.82
 -18 ± 6
 0.29
 
 Control
 128 ± 10
 119 ± 6
 0.08
  
 -9 ± 4
  
HDL cholesterol (mg/dl)
 ADF
 56 ± 3
 54 ± 4
 0.49
 0.77
 -2 ± 3
 0.51
 
 Control
 57 ± 2
 58 ± 4
 0.83
  
 1 ± 2
  
Triacylglycols (mg/dl)
 ADF
 109 ± 13
 87 ± 9
 0.06
 0.01
 -22 ± 11
 0.22
 
 Control
 108 ± 18
 118 ± 19
 0.34
  
 10 ± 7
  
Non-HDL cholesterol (mg/dl)
 ADF
 149 ± 11
 124 ± 12
 <0.01
 0.54
 -25 ± 5
 0.96
 
 Control
 153 ± 12
 144 ± 10
 0.79
  
 -9 ± 5
  
LDL particle size (Å)
 ADF
 254 ± 1
 258 ± 2
 <0.01
 <0.01
 4 ± 1
 0.13
  Control 252 ± 2 250 ± 3 0.16   -2 ± 1  

Values reported as mean ± SEM. ADF: Alternate day fasting.

1Baseline values were not significantly different between intervention groups for any parameter: Independent samples t-test.

2P-value between week 1 and week 12: Paired t-test.

3P-value between groups at week 12: Independent samples t-test.

4Absolute change between week 1 and week 12 values.

5P-value between groups for absolute change: Independent samples t-test.